Fri, March 16, 2018
Thu, March 15, 2018
Wed, March 14, 2018
Tue, March 13, 2018
Mon, March 12, 2018

Anupam Rama Maintained (SRPT) at Buy with Increased Target to $95 on, Mar 14th, 2018

Anupam Rama of JP Morgan, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $75 to $95 on, Mar 14th, 2018.

Anupam has made no other calls on SRPT in the last 4 months.



There are 5 other peers that have a rating on SRPT. Out of the 5 peers that are also analyzing SRPT, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Anupam


  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $100 on, Tuesday, March 13th, 2018
  • Joseph Schwartz of "Leerink Swann" Maintained at Buy with Increased Target to $92 on, Tuesday, March 13th, 2018
  • Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $92 on, Monday, March 12th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $64 on, Tuesday, March 6th, 2018
  • Yun Zhong of "Janney Montgomery Scott" Initiated at Strong Buy and Held Target at $75 on, Thursday, January 4th, 2018